PACTG 219C

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。本研究是一项前瞻性纵向数据收集，用于晚期结局（由于HIV疾病进展、治疗效果和/或两者的相互作用）和晚期治疗效果。这项研究是开放的儿童谁参加了ACTG治疗试验和婴儿的母亲参加了ACTG围产期治疗试验。收集的数据包括病史、体格检查、神经认知测试、临床和实验室评估、发病率、死亡率和特定时间间隔的生活质量评估。这是一项长期方案，允许我们无限期地收集临床数据。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is a prospective longitudinal data collection for late outcomes (due to HIV disease progression, treatment effects and/or an interaction of the two) and late treatment effects. The study is open to children who have participated in ACTG treatment trials and infants whose mother participated in ACTG perinatal treatment trials. Data collected included history, physical exam, neurocognitive testing, clinical and laboratory evaluations, morbidity, mortality and quality of life assessments at specific intervals. This is a long-term protocol that allows us to collect clinical data indefinitely.